Nafithromycin: advancements in antibiotic therapy against community-acquired pneumonia-resistant pathogens

Nafithromycin (WCK 4873) is a novel lactone ketolide antibiotic developed to address the critical issue of multidrug-resistant bacteria, especially those causing community-acquired pneumonia (CAP). Given the increasing prevalence of antibiotic resistance, there is a pressing need for new antibiotic...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Akshata Gore, Agadi Hiremath Viswanatha Swamy, Sanatkumar Bharamu Nyamagoud
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	PAGEPress Publications 2025-08-01
Edice:	Monaldi Archives for Chest Disease
Témata:	Nafithromycin community-acquired pneumonia multidrug-resistant bacteria lactone ketolide antibiotic pharmacokinetics
On-line přístup:	https://www.monaldi-archives.org/macd/article/view/3340
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!